TY - JOUR AU - Dangas, G. D. AU - Claessen, B. E. AU - Caixeta, A. AU - Sanidas, E. A. AU - Mintz, G. S. AU - Mehran, R. PY - 2010 DA - 2010// TI - In-stent restenosis in the drug-eluting stent era JO - J Am Coll Cardiol VL - 56 UR - https://doi.org/10.1016/j.jacc.2010.07.028 DO - 10.1016/j.jacc.2010.07.028 ID - Dangas2010 ER - TY - JOUR AU - Daemen, J. AU - Wenaweser, P. AU - Tsuchida, K. AU - Abrecht, L. AU - Vaina, S. AU - Morger, C. PY - 2007 DA - 2007// TI - Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60314-6 DO - 10.1016/S0140-6736(07)60314-6 ID - Daemen2007 ER - TY - JOUR AU - Qin, S. Y. AU - Zhou, Y. AU - Jiang, H. X. AU - Hu, B. L. AU - Tao, L. AU - Xie, M. Z. PY - 2013 DA - 2013// TI - The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0072710 DO - 10.1371/journal.pone.0072710 ID - Qin2013 ER - TY - JOUR AU - Miguel-Yanes, J. M. AU - Jimenez-Garcia, R. AU - Hernandez-Barrera, V. AU - Mendez-Bailon, M. AU - Miguel-Diez, J. AU - Lopez-de-Andres, A. PY - 2017 DA - 2017// TI - Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014) JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0609-4 DO - 10.1186/s12933-017-0609-4 ID - Miguel-Yanes2017 ER - TY - JOUR AU - Noh, M. AU - Kwon, H. AU - Jung, C. H. AU - Kwon, S. U. AU - Kim, M. S. AU - Lee, W. J. PY - 2017 DA - 2017// TI - Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0556-0 DO - 10.1186/s12933-017-0556-0 ID - Noh2017 ER - TY - JOUR AU - Yan, L. AU - Xu, M. T. AU - Yuan, L. AU - Chen, B. AU - Xu, Z. R. AU - Guo, Q. H. PY - 2016 DA - 2016// TI - Prevalence of dyslipidemia and its control in type 2 diabetes: a multicenter study in endocrinology clinics of China JO - J Clin Lipidol. VL - 10 UR - https://doi.org/10.1016/j.jacl.2015.10.009 DO - 10.1016/j.jacl.2015.10.009 ID - Yan2016 ER - TY - JOUR AU - Zhao, K. AU - Li, Y. J. AU - Gao, S. PY - 2015 DA - 2015// TI - Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting JO - Coron Artery Dis VL - 26 UR - https://doi.org/10.1097/MCA.0000000000000221 DO - 10.1097/MCA.0000000000000221 ID - Zhao2015 ER - TY - JOUR AU - Chapman, M. J. AU - Ginsberg, H. N. AU - Amarenco, P. AU - Andreotti, F. AU - Boren, J. AU - Catapano, A. L. PY - 2011 DA - 2011// TI - Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehr112 DO - 10.1093/eurheartj/ehr112 ID - Chapman2011 ER - TY - JOUR AU - Kugiyama, K. AU - Doi, H. AU - Takazoe, K. AU - Kawano, H. AU - Soejima, H. AU - Mizuno, Y. PY - 1999 DA - 1999// TI - Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease JO - Circulation. VL - 99 UR - https://doi.org/10.1161/01.CIR.99.22.2858 DO - 10.1161/01.CIR.99.22.2858 ID - Kugiyama1999 ER - TY - JOUR AU - Jacobson, T. A. AU - Ito, M. K. AU - Maki, K. C. AU - Orringer, C. E. AU - Bays, H. E. AU - Jones, P. H. PY - 2015 DA - 2015// TI - National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report JO - J Clin Lipidol. VL - 9 UR - https://doi.org/10.1016/j.jacl.2015.02.003 DO - 10.1016/j.jacl.2015.02.003 ID - Jacobson2015 ER - TY - JOUR PY - 2014 DA - 2014// TI - An International atherosclerosis society position paper: global recommendations for the management of dyslipidemia–full report JO - J Clin Lipidol. VL - 8 UR - https://doi.org/10.1016/j.jacl.2013.12.005 DO - 10.1016/j.jacl.2013.12.005 ID - ref11 ER - TY - JOUR AU - Alfonso, F. AU - Byrne, R. A. AU - Rivero, F. AU - Kastrati, A. PY - 2014 DA - 2014// TI - Current treatment of in-stent restenosis JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2014.02.545 DO - 10.1016/j.jacc.2014.02.545 ID - Alfonso2014 ER - TY - JOUR PY - 2003 DA - 2003// TI - Report of the expert committee on the diagnosis and classification of diabetes mellitus JO - Diabetes Care. VL - 26 ID - ref13 ER - TY - JOUR AU - Mansia, G. AU - Backer, G. AU - Dominiczak, A. AU - Cifkova, R. AU - Fagard, R. AU - Germano, G. PY - 2007 DA - 2007// TI - 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) JO - Blood Press VL - 16 UR - https://doi.org/10.1080/08037050701461084 DO - 10.1080/08037050701461084 ID - Mansia2007 ER - TY - JOUR AU - Board, J. B. PY - 2014 DA - 2014// TI - Joint British societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) JO - Heart. VL - 100 UR - https://doi.org/10.1136/heartjnl-2014-305693 DO - 10.1136/heartjnl-2014-305693 ID - Board2014 ER - TY - JOUR AU - Baigent, C. AU - Blackwell, L. AU - Emberson, J. AU - Holland, L. E. AU - Reith, C. AU - Bhala, N. PY - 2010 DA - 2010// TI - Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61350-5 DO - 10.1016/S0140-6736(10)61350-5 ID - Baigent2010 ER - TY - JOUR AU - Mills, E. J. AU - Wu, P. AU - Chong, G. AU - Ghement, I. AU - Singh, S. AU - Akl, E. A. PY - 2011 DA - 2011// TI - Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials JO - QJM VL - 104 UR - https://doi.org/10.1093/qjmed/hcq165 DO - 10.1093/qjmed/hcq165 ID - Mills2011 ER - TY - JOUR AU - Varbo, A. AU - Benn, M. AU - Nordestgaard, B. G. PY - 2014 DA - 2014// TI - Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment JO - Pharmacol Ther VL - 141 UR - https://doi.org/10.1016/j.pharmthera.2013.11.008 DO - 10.1016/j.pharmthera.2013.11.008 ID - Varbo2014 ER - TY - JOUR AU - Mitsutake, R. AU - Miura, S. AU - Zhang, B. AU - Saku, K. PY - 2010 DA - 2010// TI - HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography JO - Int J Cardiol VL - 143 UR - https://doi.org/10.1016/j.ijcard.2009.01.058 DO - 10.1016/j.ijcard.2009.01.058 ID - Mitsutake2010 ER - TY - JOUR AU - Fukushima, H. AU - Sugiyama, S. AU - Honda, O. AU - Koide, S. AU - Nakamura, S. AU - Sakamoto, T. PY - 2004 DA - 2004// TI - Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus JO - J Am Coll Cardiol VL - 43 UR - https://doi.org/10.1016/j.jacc.2003.09.074 DO - 10.1016/j.jacc.2003.09.074 ID - Fukushima2004 ER - TY - JOUR AU - Zhao, D. AU - Letterman, J. AU - Schreiber, B. M. PY - 2001 DA - 2001// TI - Beta-migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M103761200 DO - 10.1074/jbc.M103761200 ID - Zhao2001 ER - TY - JOUR AU - Shin, H. K. AU - Kim, Y. K. AU - Kim, K. Y. AU - Lee, J. H. AU - Hong, K. W. PY - 2004 DA - 2004// TI - Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000117403.64398.53 DO - 10.1161/01.CIR.0000117403.64398.53 ID - Shin2004 ER - TY - JOUR AU - Aramaki, Y. AU - Mitsuoka, H. AU - Toyohara, M. AU - Jinnai, T. AU - Kanatani, K. AU - Nakajima, K. PY - 2008 DA - 2008// TI - Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells JO - Atherosclerosis. VL - 198 UR - https://doi.org/10.1016/j.atherosclerosis.2007.12.017 DO - 10.1016/j.atherosclerosis.2007.12.017 ID - Aramaki2008 ER - TY - JOUR AU - Park, S. Y. AU - Lee, J. H. AU - Kim, Y. K. AU - Kim, C. D. AU - Rhim, B. Y. AU - Lee, W. S. PY - 2005 DA - 2005// TI - Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation JO - J Pharmacol Exp Ther VL - 312 UR - https://doi.org/10.1124/jpet.104.077826 DO - 10.1124/jpet.104.077826 ID - Park2005 ER - TY - JOUR AU - Yang, W. AU - Lu, J. AU - Weng, J. AU - Jia, W. AU - Ji, L. AU - Xiao, J. PY - 2010 DA - 2010// TI - Prevalence of diabetes among men and women in China JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0908292 DO - 10.1056/NEJMoa0908292 ID - Yang2010 ER - TY - JOUR AU - Tang, X. F. AU - Ma, Y. L. AU - Song, Y. AU - Xu, J. J. AU - Yao, Y. AU - He, C. PY - 2018 DA - 2018// TI - Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study JO - Cardiovasc Diabetol. VL - 17 UR - https://doi.org/10.1186/s12933-018-0758-0 DO - 10.1186/s12933-018-0758-0 ID - Tang2018 ER - TY - JOUR AU - Tani, S. AU - Yagi, T. AU - Atsumi, W. AU - Kawauchi, K. AU - Matsuo, R. AU - Hirayama, A. PY - 2017 DA - 2017// TI - Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0606-7 DO - 10.1186/s12933-017-0606-7 ID - Tani2017 ER - TY - JOUR AU - Stee, M. F. AU - Graaf, A. A. AU - Groen, A. K. PY - 2018 DA - 2018// TI - Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy JO - Cardiovasc Diabetol. VL - 17 UR - https://doi.org/10.1186/s12933-018-0738-4 DO - 10.1186/s12933-018-0738-4 ID - Stee2018 ER - TY - JOUR AU - Hattori, S. PY - 2018 DA - 2018// TI - Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance JO - J Diabetes Investig. VL - 9 UR - https://doi.org/10.1111/jdi.12781 DO - 10.1111/jdi.12781 ID - Hattori2018 ER - TY - JOUR AU - Fruchart, J. -. C. PY - 2017 DA - 2017// TI - Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0602-y DO - 10.1186/s12933-017-0602-y ID - Fruchart2017 ER -